- Home
- PHH vs BNTC Comparison
PHH vs BNTC Comparison
Compare PHH & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- BNTC
- Stock Information
- Founded
- PHH 2016
- BNTC 1995
- Country
- PHH China
- BNTC United States
- Employees
- PHH N/A
- BNTC N/A
- Industry
- PHH Package Goods/Cosmetics
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- PHH Consumer Discretionary
- BNTC Health Care
- Exchange
- PHH Nasdaq
- BNTC Nasdaq
- Market Cap
- PHH 363.4M
- BNTC 366.6M
- IPO Year
- PHH 2024
- BNTC N/A
- Fundamental
- Price
- PHH $26.57
- BNTC $14.42
- Analyst Decision
- PHH
- BNTC Strong Buy
- Analyst Count
- PHH 0
- BNTC 6
- Target Price
- PHH N/A
- BNTC $23.83
- AVG Volume (30 Days)
- PHH 420.8K
- BNTC 79.5K
- Earning Date
- PHH 01-01-0001
- BNTC 05-14-2025
- Dividend Yield
- PHH N/A
- BNTC N/A
- EPS Growth
- PHH N/A
- BNTC N/A
- EPS
- PHH 0.02
- BNTC N/A
- Revenue
- PHH $2,381,851.00
- BNTC N/A
- Revenue This Year
- PHH N/A
- BNTC N/A
- Revenue Next Year
- PHH N/A
- BNTC N/A
- P/E Ratio
- PHH $1,464.32
- BNTC N/A
- Revenue Growth
- PHH N/A
- BNTC N/A
- 52 Week Low
- PHH $3.70
- BNTC $5.74
- 52 Week High
- PHH $26.60
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- PHH N/A
- BNTC 44.90
- Support Level
- PHH N/A
- BNTC $14.42
- Resistance Level
- PHH N/A
- BNTC $17.10
- Average True Range (ATR)
- PHH 0.00
- BNTC 1.20
- MACD
- PHH 0.00
- BNTC -0.18
- Stochastic Oscillator
- PHH 0.00
- BNTC 3.66
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.